Security key
695127100
Pacira BioSciences, Inc. - Common Stock (PCRX)
CUSIP: 695127100
Q2 2018 13F Holders as of 30 Jun 2018
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 40,532,351
- Total 13F shares
- 42,889,912
- Share change
- -686,855
- Total reported value
- $1,372,185,151
- Put/Call ratio
- 280%
- Price per share
- $32.05
- Number of holders
- 148
- Value change
- -$17,981,461
- Number of buys
- 73
- Number of sells
- 77
Report period
Q2 2018
Institutions
148
Top holders
10
PCRX full security history
Newer quarter: Q3 2018
Previous quarter: Q1 2018
Pacira BioSciences, Inc. SEC filings
Pacira BioSciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 695127100
Recent filing periods:
Top shareholders of PCRX - Pacira BioSciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
8.1%
|
3,283,448
|
$102,279,000 | — | 31 Mar 2018 | |
| BlackRock Finance, Inc. |
13F
|
Company |
8%
|
3,227,911
|
$100,550,000 | — | 31 Mar 2018 | |
| Consonance Capital Management LP |
13F
|
Company |
6.5%
|
2,634,916
|
$82,078,000 | — | 31 Mar 2018 | |
| HealthCor Management, L.P. |
13F
|
Company |
5.7%
|
2,300,000
|
$71,645,000 | — | 31 Mar 2018 | |
| PointState Capital LP |
13F
|
Company |
5%
|
2,038,153
|
$63,488,000 | — | 31 Mar 2018 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
4.5%
|
1,806,268
|
$56,265,000 | — | 31 Mar 2018 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
4.2%
|
1,715,072
|
$53,424,000 | — | 31 Mar 2018 | |
| PFM Health Sciences, LP |
13F
|
Company |
4.2%
|
1,704,608
|
$53,099,000 | — | 31 Mar 2018 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
3.8%
|
1,553,114
|
$48,380,000 | — | 31 Mar 2018 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
3%
|
1,225,807
|
$38,184,000 | — | 31 Mar 2018 | |
| STATE STREET CORP |
13F
|
Company |
2.8%
|
1,155,112
|
$35,984,000 | — | 31 Mar 2018 | |
| DARUMA CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.8%
|
1,137,220
|
$35,424,000 | — | 31 Mar 2018 | |
| Rock Springs Capital Management LP |
13F
|
Company |
2.8%
|
1,125,000
|
$35,044,000 | — | 31 Mar 2018 | |
| Clearbridge Investments, LLC |
13F
|
Company |
2.7%
|
1,092,415
|
$34,029,000 | — | 31 Mar 2018 | |
| Stephens Investment Management Group LLC |
13F
|
Company |
2.6%
|
1,051,952
|
$32,768,000 | — | 31 Mar 2018 | |
| Elk Creek Partners, LLC |
13F
|
Company |
2.5%
|
1,002,311
|
$31,222,000 | — | 31 Mar 2018 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.2%
|
888,391
|
$27,673,000 | — | 31 Mar 2018 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
2.1%
|
834,282
|
$25,988,000 | — | 31 Mar 2018 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
1.8%
|
726,671
|
$22,636,000 | — | 31 Mar 2018 | |
| Epoch Investment Partners, Inc. |
13F
|
Company |
1.7%
|
701,585
|
$21,854,000 | — | 31 Mar 2018 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
1.6%
|
648,920
|
$20,214,000 | — | 31 Mar 2018 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
1.3%
|
515,132
|
$16,046,000 | — | 31 Mar 2018 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
1.3%
|
510,097
|
$15,890,000 | — | 31 Mar 2018 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
491,205
|
$15,302,000 | — | 31 Mar 2018 | |
| NEXTHERA CAPITAL LP |
13F
|
Company |
1.2%
|
478,620
|
$14,909,000 | — | 31 Mar 2018 | |
| PUTNAM INVESTMENTS LLC |
13F
|
Company |
1.1%
|
464,039
|
$14,455,000 | — | 31 Mar 2018 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
1.1%
|
461,102
|
$14,363,000 | — | 31 Mar 2018 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1%
|
417,399
|
$13,001,000 | — | 31 Mar 2018 | |
| NORGES BANK |
13F
|
Company |
1%
|
409,566
|
$12,758,000 | — | 31 Mar 2018 | |
| Penn Capital Management Company, LLC |
13F
|
Company |
0.97%
|
392,515
|
$12,328,000 | — | 31 Mar 2018 | |
| PEREGRINE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.8%
|
326,056
|
$10,157,000 | — | 31 Mar 2018 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.8%
|
325,871
|
$10,151,000 | — | 31 Mar 2018 | |
| Cortina Asset Management, LLC |
13F
|
Company |
0.8%
|
322,821
|
$10,056,000 | — | 31 Mar 2018 | |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income |
13F
|
Company |
0.76%
|
306,786
|
$9,555,000 | — | 31 Mar 2018 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.71%
|
286,510
|
$8,922,000 | — | 31 Mar 2018 | |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO |
13F
|
Company |
0.68%
|
276,888
|
$8,625,000 | — | 31 Mar 2018 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.6%
|
241,261
|
$7,515,000 | — | 31 Mar 2018 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.56%
|
226,075
|
$7,043,000 | — | 31 Mar 2018 | |
| OAK RIDGE INVESTMENTS LLC |
13F
|
Company |
0.55%
|
223,868
|
$6,973,000 | — | 31 Mar 2018 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.53%
|
214,011
|
$6,666,000 | — | 31 Mar 2018 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.48%
|
195,938
|
$6,103,000 | — | 31 Mar 2018 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.48%
|
195,274
|
$6,083,000 | — | 31 Mar 2018 | |
| Sandell Asset Management Corp. |
13F
|
Company |
0.48%
|
193,100
|
$6,015,000 | — | 31 Mar 2018 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.45%
|
180,586
|
$5,625,000 | — | 31 Mar 2018 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.42%
|
168,868
|
$5,259,000 | — | 31 Mar 2018 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.41%
|
167,469
|
$5,217,000 | — | 31 Mar 2018 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.41%
|
166,695
|
$5,193,000 | — | 31 Mar 2018 | |
| Broadfin Capital, LLC |
13F
|
Company |
0.41%
|
166,500
|
$5,186,000 | — | 31 Mar 2018 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.41%
|
165,673
|
$5,161,000 | — | 31 Mar 2018 | |
| Invesco Ltd. |
13F
|
Company |
0.4%
|
160,852
|
$5,011,000 | — | 31 Mar 2018 |
Institutional Holders of Pacira BioSciences, Inc. - Common Stock (PCRX) as of Q2 2018
As of 30 Jun 2018,
Pacira BioSciences, Inc. - Common Stock (PCRX) was held by
148 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,889,912 shares.
The largest 10 holders included
Consonance Capital Management LP, VANGUARD GROUP INC, BlackRock Inc., Partner Fund Management, L.P., HealthCor Management, L.P., MACQUARIE GROUP LTD, PRICE T ROWE ASSOCIATES INC /MD/, PointState Capital LP, venBio Select Advisor LLC, and Elk Creek Partners, LLC.
This page lists
148
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2018 vs Q1 2018 Across Filers
Q1 2018 holders
163
Q2 2018 holders
148
Holder diff
-15
| Investor | Q1 2018 Shares | Q2 2018 Shares | Share Diff | Share Chg % | Q1 2018 Value $ | Q2 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.